Sanofi’s developing a coronavirus vaccine after all
In the early days of the novel coronavirus outbreak, the list of drug companies stepping up to help was noticeably light on multinational firms that have done this before. Yesterday, the storied vaccine developer Sanofi got into the game.
As STAT’s Helen Branswell reports, Sanofi will work with the U.S. Biomedical Advanced Research and Development Authority, putting to use the technology it used in outbreaks past. It is the second major drug maker, after Johnson & Johnson, to commit to developing a vaccine for the novel virus.
It won’t be a quick process. Sanofi expects to have a vaccine candidate to test in the lab within six months and could be ready to test a vaccine in people within a year to 18 months.
Read more.
As STAT’s Helen Branswell reports, Sanofi will work with the U.S. Biomedical Advanced Research and Development Authority, putting to use the technology it used in outbreaks past. It is the second major drug maker, after Johnson & Johnson, to commit to developing a vaccine for the novel virus.
It won’t be a quick process. Sanofi expects to have a vaccine candidate to test in the lab within six months and could be ready to test a vaccine in people within a year to 18 months.
Read more.
.png)
No hay comentarios:
Publicar un comentario